Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Leukemia Cell Line, Ovarian Serous Carcinoma Cell, Breast Cancer Cell
DISEASE(S): Acute Leukemia,Malignant Neoplasm Of Ovary,Breast Cancer
SUBMITTER: Roberta Noberini
LAB HEAD: Tiziana Bonaldi
PROVIDER: PXD009946 | Pride | 2010-10-08
REPOSITORIES: Pride
Proteomics. Clinical applications 20181206 1
<h4>Purpose</h4>Profiling histone posttranslational modifications (PTMs) in clinical samples holds great potential for the identification of epigenetic biomarkers and the discovery of novel epigenetic targets. MS-based approaches to analyze histone PTMs in clinical samples usually rely on SDS-PAGE separation following histone enrichment in order to eliminate detergents and further isolate histones. However, this limits the digestions options and hence the modification coverage.<h4>Experimental d ...[more]